Bnp Paribas Asset Management Holding S.A. Ionis Pharmaceuticals Inc Transaction History
Bnp Paribas Asset Management Holding S.A.
- $41 Billion
- Q2 2025
A detailed history of Bnp Paribas Asset Management Holding S.A. transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Bnp Paribas Asset Management Holding S.A. holds 1,350,879 shares of IONS stock, worth $82.6 Million. This represents 0.13% of its overall portfolio holdings.
Number of Shares
1,350,879
Previous 1,196,392
12.91%
Holding current value
$82.6 Million
Previous $36.1 Million
47.86%
% of portfolio
0.13%
Previous 0.1%
Shares
9 transactions
Others Institutions Holding IONS
# of Institutions
413Shares Held
149MCall Options Held
1.72MPut Options Held
722K-
Vanguard Group Inc Valley Forge, PA16.7MShares$1.02 Billion0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD16MShares$982 Million0.4% of portfolio
-
Capital World Investors Los Angeles, CA12.5MShares$767 Million0.08% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$631 Million0.01% of portfolio
-
Bellevue Group Ag Kuesnacht, V87.85MShares$480 Million7.06% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $8.68B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...